Digital Content 
NEWS #PharmaBuzz
01 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/trevi-therapeutics-to-report-first-quarter-2025-financial-results-and-provide-a-corporate-update-on-may-8-2025-302444029.html
03 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/trevi-therapeutics-to-participate-in-upcoming-april-investor-conferences-302419110.html
25 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/trevi-therapeutics-completes-enrollment-for-phase-2b-coral-trial-of-haduvio-in-idiopathic-pulmonary-fibrosis-patients-with-chronic-cough-302384377.html
12 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/trevi-therapeutics-announces-positive-outcome-from-sample-size-re-estimation-resulting-in-no-change-to-the-current-sample-size-for-the-phase-2b-coral-trial-in-idiopathic-pulmonary-fibrosis-patients-with-chronic-cough-302329735.html
03 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/trevi-therapeutics-announces-positive-topline-results-from-human-abuse-potential-study-of-oral-nalbuphine-302321577.html
21 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/trevi-therapeutics-completes-enrollment-for-phase-2a-river-trial-in-refractory-chronic-cough-302281016.html
Share 